Recalls — last 90 days
- 2026-04-09CPSCSilks, of Queen Creak, ArizonaStop using Silks children's loungewear sets
The recalled children's loungewear violates mandatory flammability standards for children's sleepwear, posing a risk of serious injuries or deadly burn hazards to children.
- 2026-04-09CPSCSnooz, Inc., of Las Vegas, NevadaStop using Snooz Breez smart fan immediately
The power connector inside the fan can corrode and cause the fan to overheat, posing a risk of fire.
- 2026-04-09CPSCZhongshan Yungu Daily Products, of ChinaStop using Easymake portable bed rails
The recalled bed rails violate the mandatory standard for adult portable bed rails because users can become entrapped within the bed rail or between the bed rail and the side of the mattress, posing a serious entrapment hazard and risk of death by asphyxiation. In addition, the bed rails do not bear the required hazard warning labels.
- 2026-04-09CPSCVitaquest International LLC of West Caldwell, New JerseyStop using Vitaquest iron supplements immediately
The dietary supplements contain iron, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the supplements is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- 2026-04-09CPSCBISSELL Homecare Inc. of Grand Rapids, MichiganStop using BISSELL Steam Shot OmniReach attachments
The recalled steam cleaners' attachments can unexpectedly detach from the steam cleaners and expel hot water or steam onto users during use, posing a serious burn hazard.
- 2026-04-09CPSCWybotics, Co. Ltd. of Tianjin, ChinStop using Wybotics robotic pool vacuums
The lithium-ion battery in the recalled pool vacuums can overheat, posing burn and fire hazards to consumers.
- 2026-04-08FDA-PRBlaine Labs, IncStop using Blaine Labs wound care gel
Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the consumer level due to microbial contamination.
- 2026-04-08FDA-DeviceCardinal Health 200, LLCClass IICheck Cardinal Health Monoject Tuberculin Syringes
The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.
- 2026-04-08FDA-DeviceGE Healthcare LLCClass IICheck your GE SIGNA Premier MRI scanner
Whole-Body MR scanners used to produce images of the inside of the human body to aid diagnosis of disease may have been manufactured/serviced with ferrous (steel) fittings instead of non-ferrous (brass) fittings on the magnet rear and if system is accessed to perform service while the magnet is ramped, the magnetic field could attract the ferrous fittings potentially resulting in personnel injury.
- 2026-04-08FDA-DeviceOxoid Australia Pty LimitedClass IIStop using Oxoid Microbact 12L Kit lot 4494873
Oxoid Ltd., part of Thermo Fisher Scientific, confirmed that Microbact 12L Kit 20 Tests MB1128A lot 4494873 may identify incorrect organism due to inconclusive result from ambiguous color reactions in wells.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical Kilt Blockers
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical Blockers serial number
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical apron serial number
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck Burlington Medical half aprons for material degradation
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical leg wraps
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck Burlington Medical caps for degradation
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck Burlington Medical protective sleeves
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIStop using Burlington Medical BAT aprons
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IIStop using Burlington Medical wrap aprons
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical frontal apron
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical Kilt model
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck Burlington Medical vest serial number
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceBurlington Medical, LLCClass IICheck your Burlington Medical Thyroid Shield
Potential for attenuation degradation over time, decreasing the lifespan.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your Medtronic MiniMed insulin pump positioning
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIStop using affected Medtronic MiniMed insulin pumps
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your Medtronic MiniMed insulin pump position
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIStop using Medtronic MiniMed Paradigm insulin pump
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIStop using affected Medtronic MiniMed insulin pumps
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IIStop using affected Medtronic MiniMed insulin pumps
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
- 2026-04-08FDA-DeviceMedtronic MiniMed, Inc.Class IICheck your Medtronic MiniMed insulin pump position
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.